More competition, not price controls, is key to cheaper medicines, says pharma expert

As the Supreme Court questions gaps in medicine price regulation, former pharma counsel Murali Neelakantan argues that competition, distribution margins and government procurement deserve greater attention.
Read the full report on Cnbctv18
Story file
- Section
- India
- Topics
- Courts & law
- First reported by
- Cnbctv18
- Reporter
- swapnil deshpande
- Published
- Monday, 12 October 2026, 9:10 pm IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Cnbctv18 with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.






